Determinants of fibrinogen level among South Asians are not established. In 1997-1999, plasma fibrinogen levels and prevalences of the fibrinogen polymorphisms Aα Thr312Ala, β-445G/A, and Bβ Arg448Lys and correlates were compared among 100 apparently healthy United Kingdom South Asians and 100 age-and sexmatched Whites. Mean fibrinogen levels were higher in South Asians (3.33 g/liter, 95% confidence interval (CI): 3.16, 3.51) than in Whites (2.84 g/liter, 95% CI: 2.72, 2.96) (p < 0.0001), but genotype distributions were similar. Bβ Arg448Lys was related to fibrinogen in South Asians (RR (n = 67): 3.22 g/liter, 95% CI: 3.03, 3.43; RK (n = 26): 3.72 g/liter, 95% CI: 3.65, 4.11; KK (n = 7): 3.07 g/liter, 95% CI: 2.53, 3.72) (p = 0.04) and Whites (p = 0.06). β-455G/A was related to fibrinogen in Whites (GG (n = 56): 2.68 g/liter, 95% CI: 2.56, 2.86; GA (n = 37): 2.97 g/liter, 95% CI: 2.79, 3.17; AA (n = 5): 3.22 g/liter, 95% CI: 2.85, 3.65) (p = 0.02) and South Asians (p = 0.07). After adjustment for age, gender, body mass index, hypertension, cholesterol, triglycerides, smoking, Aα Thr312Ala, and β-455G/A, fibrinogen levels remained significantly higher in South Asians (3.56 g/liter, 95% CI: 3.35, 3.77) than in Whites (3.03 g/liter, 95% CI: 2.85, 3.22) (p < 0.0001). These findings suggest that increased fibrinogen levels among South Asians versus Whites are not due to differences in the prevalence of genetic polymorphisms that encode for fibrinogen. Am J Epidemiol 2002;156:174-9. ethnic groups; fibrinogen; genotype; polymorphism (genetics) Abbreviations: PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.
South Asians (migrants from India, Pakistan, and Bangladesh) residing in the United Kingdom have increased morbidity and mortality from coronary artery disease and cerebrovascular disease in comparison with the indigenous White population (1) . Conventional risk factors do not fully explain the increased mortality, and the role of hemostatic factors is being increasingly recognized for ischemic vascular disease. Levels of fibrinogen are higher among South Asians as compared with Whites in some studies (2) (3) (4) (5) , but the determinants of high fibrinogen levels in South Asians have not been elucidated.
An elevated plasma fibrinogen level has been established to be an independent predictor of coronary artery disease, stroke, and peripheral vascular disease in Whites (6) , and factors influencing circulating levels of fibrinogen in these subjects include age, gender, smoking, and genetic factors. There is evidence that up to 51 percent of the variation in fibrinogen levels may be due to genetic factors, and a relation between the Bβ Arg448Lys, β-455G/A, and Aα Thr312Ala polymorphisms and fibrinogen level has been reported (7) .
Our aim in this study was to determine whether the Thr312Ala polymorphism of the Aα fibrinogen gene, the β-455G/A and Arg448Lys polymorphisms of the Bβ fibrinogen gene, and associations between fibrinogen and the fibrinogen genotype and classical cardiovascular disease risk factors differ in South Asian and White subjects who are free of clinically detectable vascular disease.
MATERIALS AND METHODS
We recruited 100 White subjects and 100 South Asian subjects from the county of West Yorkshire, United Kingdom. South Asians were identified at random over a 2-year period (1997) (1998) (1999) from West Yorkshire Health Authority local general practice registers. South Asians were defined as persons residing in the United Kingdom who had migrated from India, Pakistan, or Bangladesh or had four grandparents from one of these three countries. The South Asian subjects originating from India were all Hindus, and those originating from Pakistan and Bangladesh were all Muslims. An age-(±2 years) and sex-matched White subject was selected for each South Asian subject. White subjects were all of Caucasian origin, had been born in the United Kingdom, and were randomly selected from West Yorkshire Health Authority general practice age-sex registers. Subjects with mixed parentage were not included in the study.
All of the subjects were contacted by mail. A volunteer information sheet written in both English and various South Asian languages (namely Gujrati, Punjabi, Bengali, Hindi, and Urdu), according to the subject's ethnic background, was sent. More than 50 percent of the subjects contacted agreed to take part in the study. Subjects were seen in their homes or at a hospital. Self-reported clinical history and information on medication use, including history of and treatment for hypertension and type 2 diabetes mellitus, was recorded for all persons. All of the study subjects were free of clinically detectable stroke, ischemic heart disease, and peripheral vascular disease; this was established with a detailed medical history and a clinical examination conducted according to a specific protocol. Since cancer and inflammatory diseases may elevate fibrinogen levels, subjects with a known history of these conditions were not included.
All subjects gave informed consent according to a protocol approved by the research ethics committees of the United Leeds Teaching Hospitals NHS Trust and the Bradford Hospitals NHS Trust.
All anthropometric measurements were made while the subject was wearing light clothing. Weight was determined to the nearest 0.1 kg and height to the nearest 0.1 cm. Body mass index was calculated as weight (kg) divided by height (m) 2 . Blood pressure was measured in the supine position after 15 minutes' rest, and the mean of three readings taken to the nearest 2 mm of mercury was used. Subjects who had never smoked were classified as nonsmokers, and those who were former smokers or current smokers were classified as smokers.
Samples of free-flowing venous blood were drawn after an overnight fast. Samples for the measurement of circulating fibrinogen were taken into 0.1 M trisodium citrate, centrifuged at 2,500 × g at room temperature, and stored at -40°C. Fibrinogen levels were determined by the Clauss method (8) on a KC10 coagulometer (Amelung, Lemgo, Germany); the interassay coefficient of variation was 3.5 percent, and the intraassay coefficient of variation was 2 percent.
DNA analysis
Genomic DNA was extracted from 10 ml of whole blood taken into ethylenediaminetetraacetic acid. Fibrinogen Bβ Arg448Lys genotype was determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) as previously described (9) , and genotype was classified as RR (arginine, arginine), RK (arginine, lysine), or KK (lysine, lysine). Aα Thr312Ala was analyzed by PCR-RFLP as previously described (9) , and genotype was classified as TT (threonine, threonine), TA (threonine, alanine), or AA (alanine, alanine). β-455G/A was analyzed by PCR-RFLP using newly designed primers (forward 5′-GCT TGT GGG AAA TGA AGG AA-3′; reverse 5′-GGC AAC CAC TAA AAT CGT GA-3′). Overnight digestion with HaeIII gave rise to a constant band of 26 base pairs and to bands of 383 base pairs and 86 base pairs in the presence of the guanosine allele and a single band of 469 base pairs in the presence of the adenosine allele. β-455G/A genotype was classified as GG, GA, or AA.
Statistical analysis
Data on fibrinogen, triglyceride, and body mass index were log-transformed to normalize their distributions. Differences in continuous variables between the two groups were compared by independent sample t test; differences between more than two groups were compared by one-way analysis of variance for real difference, with results being expressed as mean (or geometric mean) values and 95 percent confidence intervals. Differences in categorical variables were determined by χ 2 test. Linkage disequilibrium coefficients were estimated using the maximum likelihood method of Weir and Cockerham (10), as exemplified for the Bβ Arg448Lys fibrinogen gene polymorphism by Baumann and Henschen (11) . Linear regression analysis was carried out to identify independent predictors of plasma fibrinogen level, and interaction terms between ethnicity and other covariates (age, gender, body mass index, cholesterol, triglycerides, smoking, hypertension, and the Aα Thr312Ala and β-455G/A polymorphisms) were included to determine differences in regression slopes between South Asians and Whites. Statistical significance was expressed at p < 0.05. Statistical analyses were carried out using SPSS, version 9.0 (SPSS, Inc., Chicago, Illinois).
RESULTS
The characteristics of White and South Asian subjects are presented in The distributions of genotypes were in Hardy-Weinberg equilibrium in both groups, except for β-455G/A in South Asians (data not shown). The Bβ Arg448Lys and β-455G/A fibrinogen polymorphisms were in linkage disequilibrium among both South Asians (D′ = 87.08 percent, p < 0.0001) and Whites (D′ = 100 percent, p < 0.0001). In Whites, but not in South Asians, significant linkage disequilibrium was evident between the Aα Thr312Ala and β-455G/A polymorphisms (D′ = 63.71 percent, p < 0.03) and the Aα Thr312Ala and Bβ Arg448Lys polymorphisms (D′ = 76.88 percent, p < 0.03). There was no significant difference in the genotype distribution of the Aα Thr312Ala, Bβ Arg448Lys, or β-455G/A polymorphism between the two groups (table 2). Fibrinogen levels were higher in both South Asians and Whites possessing the Bβ 448Lys and β-455A alleles (table  3) .
The measures of effect and regression coefficients for factors related to plasma fibrinogen are presented in table 4. After accounting for covariates (age, gender, body mass index, cholesterol, triglycerides, smoking, hypertension, and the Aα Thr312Ala and β-455G/A polymorphisms), fibrin- Other factors independently associated with plasma fibrinogen were age, gender, body mass index, smoking, and β-455G/A; however, the largest contributor to fibrinogen levels was ethnicity, which contributed to 17 percent of the variation (p < 0.0001). When the Bβ Arg448Lys polymorphism replaced the β-455G/A polymorphism in this model, the contribution to fibrinogen levels (R 2 = 3.4 percent, p = 0.01) was smaller than that with β-455G/A (R 2 = 4.1 percent, p = 0.006). We created interaction terms between ethnicity and other factors to determine differences in regression slopes between South Asians and Whites. There were no significant interactions between genotype and ethnicity. The only significant interaction observed was with triglycerides (p = 0.03): There was a positive association between fibrinogen and triglycerides in Whites and a negative association in South Asians.
DISCUSSION
There is considerable evidence that in White subjects, elevated plasma fibrinogen levels are significantly associated with cardiovascular disease (6, (12) (13) (14) . Plasma fibrinogen is associated with most conventional risk factors for cardiovascular disease, including age, sex, smoking, hypertension, and diabetes mellitus, with at least 25 percent of the interindividual variation in fibrinogen levels being attributable to the presence of these risk factors (12, (15) (16) (17) (18) . There is also evidence that up to 51 percent of the variation in fibrinogen levels is determined by genetic factors (19, 20) . There are limited data regarding levels of fibrinogen and its determinants in South Asians, who have increased mortality from cardiovascular disease in comparison with Whites (1-4).
In keeping with previous reports, we have demonstrated a high degree of linkage disequilibrium between the β-fibrinogen Bβ-455G/A and Bβ Arg448Lys polymorphisms in both South Asians and Whites (11, 21) . There were no differences in genotype distributions for Aα Thr312Ala, β-455G/A, and Bβ Arg448Lys in South Asians and Whites. We have demonstrated increased fibrinogen levels in persons possessing the β-455A and Bβ 448Lys alleles, although the magnitude of the effect appeared greater for β-455G/A in linear regression models. Since β-455G/A occurs in the promoter region of the β-fibrinogen gene, these data suggest that the association of Bβ Arg448Lys with fibrinogen levels reflects the strong linkage disequilibrium with β-455G/A. It is interesting that in Whites the association appeared to be dose-related, whereas in South Asians levels were elevated among those heterozygous but not those homozygous for rarer alleles. This has been observed in a number of studies. The explanation is unclear, but it is likely to reflect the small numbers of subjects who are homozygous for the rare alleles (20) . The results from a number of previous studies have varied, with the most consistent associations between the β-455G/A genotype and fibrinogen being observed in male smokers (7, 22) . However, the relatively small number of smokers among South Asians and Whites, especially females, in the present study precluded these subanalyses.
In this study, we have demonstrated that plasma fibrinogen levels are elevated among high-risk South Asian subjects in comparison with their White counterparts. In contrast, ethnic groups with a lower prevalence of ischemic heart diseasefor instance, the Greenland Inuit (23) and the Japanese (24)-have been found to have lower fibrinogen levels than Whites. These observations suggest that plasma fibrinogen levels mirror the incidence of atherothrombotic disease in different populations. In addition, in the Inuit and Japanese groups studied (23, 24) , there was a decreased prevalence of the β-fibrinogen β-455A allele, and this might partly account for the lower levels of plasma fibrinogen observed in these subjects. However, in the present study, there was no corresponding increased incidence of the β-455A allele to account for the observed increase in plasma fibrinogen levels among South Asians. There were no differences in the association of conventional cardiovascular disease risk factors and correlates of fibrinogen between South Asians and Whites, except for triglycerides, for which there was a positive association between fibrinogen and triglycerides in Whites and a negative association in South Asians. The implication of this finding is unknown and warrants further investigation, but clearly this observation does not account for the observed increase in fibrinogen levels in South Asians. After covariates were accounted for, fibrinogen levels were 0.53 g/liter higher in South Asians than in Whites. Since it was demonstrated in the Northwick Park Heart Study that an increase in plasma fibrinogen of 0.6 g/liter was associated with an 84 percent increased risk of ischemic heart disease over the ensuing 5 years (12), it is probable that elevated fibrinogen levels may be contributing to the increased risk of cardiovascular disease in South Asians.
Fibrinogen levels are influenced by variations in healthrelated behaviors (25, 26) , and energy restriction combined with physical activity lowers fibrinogen levels in adolescents (27) . In this study, we did not take diet and exercise into consideration. Moreover, this study was carried out among South Asians living in the United Kingdom. The Western diet might be playing a role in increasing fibrinogen levels among these South Asians. While it is tempting to attribute ethnic differences to genetic differences, our data imply that factors other than the most obvious genetic polymorphisms (dietary factors, environmental factors, migration, and/or genetic factors) need to be considered. Therefore, it will be necessary to conduct prospective studies among different groups of South Asians, both in their native countries and in the United Kingdom, to further elucidate the role of elevated fibrinogen levels in the incidence of cardiovascular disease.
South Asian populations are heterogeneous (28) , and because of the relatively small numbers of subjects in this study, it was not possible to carry out analyses of South Asian ethnic subgroups compared with Whites. Although Bhopal et al. (28) reported differences in a number of cardiovascular disease risk factors between South Asian ethnic subgroups (Indians, Pakistanis, and Bangladeshis) living in the United Kingdom (Newcastle upon Tyne), we found no significant differences in any of the conventional cardiovascular disease risk factors between these ethnic subgroups in our study. Therefore, we considered it reasonable to combine the South Asian ethnic subgroups for all subsequent analyses.
Twenty percent of our South Asian population had type 2 diabetes and 18 percent had hypertension, both of which are associated with vascular disease. However, the elevated fibrinogen level in South Asians was independent of the presence of these cardiovascular disease risk factors. In addition, fibrinogen levels remain elevated in South Asians compared with Whites when age-matched subjects without diabetes are analyzed. The prevalence of hypertension and type 2 diabetes in South Asians noted in this study was entirely representative of this ethnic group in the United Kingdom (29) .
In conclusion, fibrinogen levels in South Asians are determined by gender, smoking, and Bβ Agr448Lys polymorphisms but not by type 2 diabetes or hypertension. However, elevated fibrinogen levels in high-risk United Kingdom South Asians versus Whites are not explained by differences in known polymorphisms or known covariates. Therefore, additional research is needed for further elucidation. 
